J.P. Marvel Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.24M | Buy |
|
|||||
|
2025
Q2 | $2.23M | Buy |
|
|||||
|
2025
Q1 | $1.08M | Hold |
|
|||||
|
2024
Q4 | $941K | Hold |
|
|||||
|
2024
Q3 | $1.1M | Hold |
|
|||||
|
2024
Q2 | $972K | Hold |
|
|||||
|
2024
Q1 | $598K | Hold |
|
|||||
|
2023
Q4 | $766K | Hold |
|
|||||
|
2023
Q3 | $708K | Hold |
|
|||||
|
2023
Q2 | $760K | Hold |
|
|||||
|
2023
Q1 | $801K | Hold |
|
|||||
|
2022
Q4 | $951K | Sell |
|
|||||
|
2022
Q3 | $802K | Hold |
|
|||||
|
2022
Q2 | $585K | Hold |
|
|||||
|
2022
Q1 | $654K | Hold |
|
|||||
|
2021
Q4 | $680K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $339K | Sell |
|
|||||
|
2021
Q1 | $339K | Hold |
|
|||||
|
2020
Q4 | $312K | Sell |
|
|||||
|
2020
Q3 | $427K | Hold |
|
|||||
|
2020
Q2 | $434K | Hold |
|
|||||
|
2020
Q1 | $319K | Buy |
|
|||||
|
2019
Q4 | $230K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $238K | Hold |
|
|||||
|
2017
Q4 | $254K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $698K | Sell |
|
|||||
|
2016
Q3 | $3.75M | Buy |
|
|||||
|
2016
Q2 | $2.9M | Sell |
|
|||||
|
2016
Q1 | $3.29M | Buy |
|
|||||
|
2015
Q4 | $4.83M | Buy |
|
|||||
|
2015
Q2 | $6.16M | Sell |
|
|||||
|
2015
Q1 | $5.41M | Sell |
|
|||||
|
2014
Q4 | $5.1M | Sell |
|
|||||
|
2014
Q3 | $4.79M | Buy |
|
|||||
|
2014
Q2 | $3.43M | Buy |
|
|||||
|
2014
Q1 | $3.56M | Sell |
|
|||||
|
2013
Q4 | $3.48M | Buy |
|
|||||
|
2013
Q3 | $3.46M | Buy |
|
|||||
|
2013
Q2 | $1.55M | Buy |
|